NeoTract, Inc.'s Minimally Invasive UroLift System For Enlarged Prostate Now Shown To Be Durable Through Five Years: Results From Pivotal L.I.F.T. Randomized Study Presented Post author:Sam Post published:March 26, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Athenex, A US-China Cancer Company, Stages $66 Million U.S. IPO June 15, 2017 The Next Biotech 'Unicorn,' Ginkgo Bioworks, Just Nabbed Another $275M December 13, 2017 Lilly's Cyramza Fails to Improve Overall Survival in Phase III Gastric Cancer Study December 10, 2017
Lilly's Cyramza Fails to Improve Overall Survival in Phase III Gastric Cancer Study December 10, 2017